NeuBase terminates CEO Dietrich Stephan; appoints CFO Todd Branning as interim CEO

NeuBase Therapeutics, Inc.

Board terminated Dietrich A. Stephan as CEO without cause, effective Jan 16, 2024.
Todd P. Branning, CFO since Jan 2022, appointed interim CEO, retaining CFO role.
Dr. Stephan expected to continue serving on the Board.
Branning's compensation unchanged as a result of the appointment.
No family relationships or material transactions with Branning disclosed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Todd P. Branning

interim Chief Executive Officer

NeuBase Therapeutics, Inc.

Effective: 2024-01-16
Filed: January 17, 2024, 6:59 PM ET

appointed Todd P. Branning, who has served as the Company’s Chief Financial Officer since January 2022, as the Company’s interim Chief Executive Officer

Departed

Dietrich A. Stephan

Chief Executive Officer

NeuBase Therapeutics, Inc.

Effective: 2024-01-16
Successor: Todd P. Branning
Filed: January 17, 2024, 6:59 PM ET

terminated the employment of Dietrich A. Stephan, Ph.D. as Chief Executive Officer of the Company, without cause

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Todd P. Branning was appointed as interim Chief Executive Officer at NeuBase Therapeutics, Inc..

Action: appointed
Role: interim Chief Executive Officer

Exact text from the filing

appointed Todd P. Branning, who has served as the Company’s Chief Financial Officer since January 2022, as the Company’s interim Chief Executive Officer

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Dietrich A. Stephan was terminated as Chief Executive Officer at NeuBase Therapeutics, Inc..

Action: terminated
Role: Chief Executive Officer

Exact text from the filing

terminated the employment of Dietrich A. Stephan, Ph.D. as Chief Executive Officer of the Company, without cause

View on SEC.gov

Source: SEC EDGAR

accession 0001104659-24-004247

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.